|
|
||||||||
(TNF-
), Interleukin-6 (IL-6), and Interleukin-1ß (IL-1ß) in Dengue-Infected Patients
Sensitive immunoenzymatic assays were used to study the levels of tumor necrosis factor-
(TNF-
), interleukin-6 (IL-6), and IL-1ß in sera from dengue-infected patients obtained during the 19891990 outbreak of dengue-3 in Tahiti, French Polynesia. The patients, both children (n = 47) and adults (n = 18), were clinically classified as having dengue hemorrhagic fever (DHF) and graded according to the severity of illness (grade I = fever, grade II = fever with spontaneous hemorrhagic manifestations, grade III = circulatory failure, grade IV = deep shock). The serum samples were obtained from day 1 to day 10 after the onset of the disease. High levels of TNF-
were observed in dengue-infected children of all severity grades. The highest values of TNF-
were found before day 6 after the onset of the infection, these values decreased from day 6 to day 10. The highest values were observed in sera from grade III and IV patients. High values of IL-6 were observed in serum samples of grade I and II patients on day 1, which decreased on day 4, and by day 5 were similar to those obtained from 25 control children. In grade III and IV patients, the highest values of IL-6 were observed from day 3 to day 5 after the onset of infection; after day 5, these values were very low. The highest values of IL-6 in grade III patients were accompanied by elevated values of TNF-
and were observed in serum obtained on the day the patient went into shock (dengue shock syndrome [DSS]). The IL-6 values were normal one day before and one day after the patient went into shock. The values of IL-1ß were similar to those of 25 control children. Serum samples from dengue-infected adults, obtained from day 4 to day 10 after the onset of disease, showed moderately high levels of TNF-
compared with those of dengue-infected children. In some adult patients, IL-6 values increased and in all the patients, IL-1ß values were similar to those of healthy adults. Our results show an inconsistency in TNF-
and IL-6 production in dengue-infected patients that probably has important implications in the physiopathology of DHF/DSS.
This article has been cited by other articles:
![]() |
T. R. Prestwood, D. M. Prigozhin, K. L. Sharar, R. M. Zellweger, and S. Shresta A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads J. Virol., September 1, 2008; 82(17): 8411 - 8421. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tang, Z. Kou, X. Tang, F. Zhang, X. Yao, S. Liu, and X. Jin Unique Impacts of HBV Co-infection on Clinical and Laboratory Findings in a Recent Dengue Outbreak in China Am J Trop Med Hyg, August 1, 2008; 79(2): 154 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wati, P. Li, C. J. Burrell, and J. M. Carr Dengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF-{alpha}), and DV Infection Induces Altered Responsiveness to TNF-{alpha} Stimulation J. Virol., September 15, 2007; 81(18): 10161 - 10171. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, R.-F. Chen, J.-W. Liu, H.-R. Yu, H.-C. Kuo, and K. D. Yang Implications of Dynamic Changes among Tumor Necrosis Factor-{alpha} (TNF-{alpha}), Membrane TNF Receptor, and Soluble TNF Receptor Levels in Regard to the Severity of Dengue Infection Am J Trop Med Hyg, August 1, 2007; 77(2): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Sariol, J. L. Munoz-Jordan, K. Abel, L. C. Rosado, P. Pantoja, L. Giavedoni, I. V. Rodriguez, L. J. White, M. Martinez, T. Arana, et al. Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1 Clin. Vaccine Immunol., June 1, 2007; 14(6): 756 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Chen, F. M. Hofman, J. T. Kung, Y.-D. Lin, and B. A. Wu-Hsieh Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage J. Virol., June 1, 2007; 81(11): 5518 - 5526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Srikiatkhachorn, C. Ajariyakhajorn, T. P. Endy, S. Kalayanarooj, D. H. Libraty, S. Green, F. A. Ennis, and A. L. Rothman Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever J. Virol., February 15, 2007; 81(4): 1592 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. DEAUVIEAU, V. SANCHEZ, C. BALAS, A. KENNEL, A. DE MONTFORT, J. LANG, and B. GUY INNATE IMMUNE RESPONSES IN HUMAN DENDRITIC CELLS UPON INFECTION BY CHIMERIC YELLOW-FEVER DENGUE VACCINE SEROTYPES 1-4 Am J Trop Med Hyg, January 1, 2007; 76(1): 144 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shresta, K. L. Sharar, D. M. Prigozhin, P. R. Beatty, and E. Harris Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability. J. Virol., October 1, 2006; 80(20): 10208 - 10217. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-C. CHEN, H.-Y. LEI, C.-C. LIU, S.-C. SHIESH, S.-H. CHEN, H.-S. LIU, Y.-S. LIN, S.-T. WANG, H.-W. SHYU, and T.-M. YEH CORRELATION OF SERUM LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR WITH DISEASE SEVERITY AND CLINICAL OUTCOME IN DENGUE PATIENTS Am J Trop Med Hyg, January 1, 2006; 74(1): 142 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Lin, S.-C. Chiu, Y.-L. Hsiao, S.-W. Wan, H.-Y. Lei, A.-L. Shiau, H.-S. Liu, T.-M. Yeh, S.-H. Chen, C.-C. Liu, et al. Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 1 J. Immunol., January 1, 2005; 174(1): 395 - 403. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |